Pain and dyspnea control during awake fiberoptic bronchoscopy in critically ill patients: safety and efficacy of remifentanil target-controlled infusion

Annals of Intensive Care

Table 3 Physiological parameters at baseline, during the procedure and after 1 h (median [IQR])

	Baseline	Minimal per-procedure	Maximal per-procedure	After 1 h
SpO₂ (%)	97 [94–99]	94 [92–97]*	99 [97–100]*	97 [95–99] p = 0.244
RR (cycles/min)	27 [20–31]	18 [12–22]*	30 [24–36]*	23 [20–28] p = 0.004
HR (beats/min)	100 [83–111]	95 [77–107]*	106 [93–124]*	94 [83–106] p = 0.026
SAP (mmHg)	139 [118–149]	126 [110–137]*	151 [139–168]*	130 [118–137] p = 0.052
MAP (mmHg)	93 [83–101]	87 [80–95]*	104 [93–113]*	89 [81–98]*

SpO₂: oxygen saturation by pulse oximetry, RR: respiratory rate, HR: heart rate, SAP: systolic arterial pressure, MAP: mean arterial pressure. Parameters compared with baseline with paired Wilcoxon test
^*p < 0.001